Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
05 Mars 2024 - 2:30PM
Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading
radiopharmaceutical-focused company committed to enabling
clinicians to Find, Fight and Follow disease to deliver better
patient outcomes, today announced Paul Blanchfield, President, will
present at the Leerink Partners Global Biopharma Conference 2024 at
9:20 a.m. ET on Tuesday, March 12.
To access a live webcast of the presentation, please visit
the Investors section of the Company’s website at
www.lantheus.com. A replay of the webcast will be available on the
Company’s website for at least 30 days following the live
presentation.
About Lantheus Lantheus is the leading
radiopharmaceutical-focused company, delivering life-changing
science to enable clinicians to Find, Fight and Follow disease to
deliver better patient outcomes. Headquartered in Massachusetts
with offices in New Jersey, Canada and Sweden, Lantheus has been
providing radiopharmaceutical solutions for more than 65 years. For
more information, visit www.lantheus.com.
Contacts:Mark KinarneyVice President, Investor
Relations978-671-8842ir@lantheus.com
Melissa Downs Senior Director, External
Communications646-975-2533media@lantheus.com
Lantheus (NASDAQ:LNTH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Lantheus (NASDAQ:LNTH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024